Web胃癌 JCOG9912. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Boku N, Yamamoto S, Fukuda … WebIn the JCOG 9912 study, the percentage was approximately 83%, showing a 31% increase. This difference may also have led to the MST difference of 3.7 months. Even after adjusting for baseline factors, TTF was similar in the two studies; however, both OS and OS-TTF were longer in the JCOG 9912 study than in the JCOG 9205 study. It was concluded
[Combination chemotherapy of TS-1 +cisplatin for inoperable gastric ...
WebIn the JCOG 9912 study, the percentage was approximately 83%, showing a 31% increase. This difference may also have led to the MST difference of 3.7 months. Even after … Web25 mar 2014 · By using patient data from the Japan Clinical Oncology Group (JCOG) 9912 trial, we explored baseline prognostic factors and prognostic index. In the results, a novel … twilight photography in the magic hour
[Combination chemotherapy of TS-1 +cisplatin for inoperable …
WebAccording to the results of Japanese phase III trials recently reported such as JCOG 9912 and SPIRITS, there was a remarkable improvement in median survival time compared to … Web25 mar 2014 · By using patient data from the Japan Clinical Oncology Group (JCOG) 9912 trial, we explored baseline prognostic factors and prognostic index. In the results, a novel prognostic index consisting of four risk factors (performance status ≥1, metastatic sites ≥2, no prior gastrectomy, and elevated ALP), which can classify patients into three risk … Web4 mar 2008 · Surprisingly, compared with the earlier JCOG 9205 trial, MST was prolonged by over 4 months in the JCOG 9912 trial. Many new chemotherapeutic agents (e.g., S-1, CPT-11, docetaxel and paclitaxel) were administered in the JCOG 9912 trial, which were not available at the time of the earlier JCOG 9205 study. twilight photo editing services